Primary Phase Ib Analysis of Beamion LUNG-1: Zongertinib (BI 1810631) in Patients with HER2 Mutation-Positive NSCLC - Ruiter, G; Tu, H; Ahn, M; Yoh, K; Zugazagoitia, J; Smit, E; Wu, Y; Planchard, D; Cho, B; Wehler, B; Zhao, Y; Wehler, T; von Wangenheim, U; Rohrbacher, M; Sadrolhefazi, B; Lin, G; Yu, Y; Nadal, E; Heymach, J (Pneumologie, 2025)